{"filing":{"accession_number":"0001437749-26-023248","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"amix20260709_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926023248/amix20260709_8k.htm"},"events":[{"id":16989,"run_id":15211,"accession_number":"0001437749-26-023248","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"summary":"The filing discloses that Autonomix Medical received a deficiency letter on January 14, 2026 for failing the Nasdaq Bid Price Rule (stock below $1.00 per share for 30 consecutive business days), which triggered delisting risk. Although the company subsequently regained compliance by July 9, 2026, the core event disclosed is the prior delisting threat and its resolution. This is material to investors as it reflects the company's historical struggle to maintain listing standards and demonstrates the company was at material risk of delisting.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15267,"accession_number":"0001437749-26-023248","item_number":"8.01","item_title":"Other Events","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"reasoning":"The filing discloses that Autonomix Medical received a deficiency letter on January 14, 2026 for failing the Nasdaq Bid Price Rule (stock below $1.00 per share for 30 consecutive business days), which triggered delisting risk. Although the company subsequently regained compliance by July 9, 2026, the core event disclosed is the prior delisting threat and its resolution. This is material to investors as it reflects the company's historical struggle to maintain listing standards and demonstrates the company was at material risk of delisting.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:33:43.957390+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15267,"accession_number":"0001437749-26-023248","item_number":"8.01","item_title":"Other Events","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.85,"reasoning":"The filing discloses that Autonomix Medical received a deficiency letter on January 14, 2026 for failing the Nasdaq Bid Price Rule (stock below $1.00 per share for 30 consecutive business days), which triggered delisting risk. Although the company subsequently regained compliance by July 9, 2026, the core event disclosed is the prior delisting threat and its resolution. This is material to investors as it reflects the company's historical struggle to maintain listing standards and demonstrates the company was at material risk of delisting.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:33:43.957390+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-10"}]}